As the founder of Avalere Health, Dan advises the firm and is a well-known speaker on the future of healthcare.

Prior to founding Avalere in 2000, Dan served as associate director for health at the White House Office of Management and Budget.

Dan presently serves on the Board of Champions Oncology (CSBR) and is executive in residence at the Fuqua School of Business at Duke University. He previously served on the boards of Coventry Healthcare (sold to Aetna in 2013), PharMerica Corporation (PMC), and HMS holdings (HMSY).

Dan speaks frequently and is frequently quoted in the media on business strategy and policy matters—often highlighting the outstanding analytic work of the Avalere staff. He has an MPP from the Kennedy School of Government at Harvard University and a BA in economics and viola performance from Oberlin College.

Authored Content


Tune in to hear the first episode in our 3-part series covering the mid-term elections and potential implications on health policy. Avalere expert, Chris Sloan, discusses potential implications of the mid-term elections on health policy. To kick off the series Avalere Founder, Dan Mendelson, covers pre-existing conditions.

New analysis from Avalere finds that 102 million individuals, not enrolled in major public programs like Medicaid or Medicare, have a pre-existing medical condition and could therefore face higher premiums or significant out-of-pocket costs if the ACA’s pre-existing condition protections were repealed.

New research from Avalere finds that Medicare Advantage (MA) beneficiaries with hypertension, hyperlipidemia, and diabetes experienced significantly fewer inpatient stays and emergency room visits relative to those in traditional fee-for-service (FFS) Medicare.

Patient out-of-pocket costs continue to grow despite policies to increase affordability for beneficiaries.

Avalere's founder and president, Dan Mendelson, recently sat down with Senior Housing News editors to discuss opportunities for senior living providers to leverage data to facilitate synergistic partnerships with payers.

New research from Avalere finds Medicare beneficiaries are spending fewer days in skilled nursing facilities (SNFs) since 2009 on a per capita basis.

New analysis from Avalere finds that the proposed rule on association health plans (AHPs) is projected to lead to 3.2M enrollees shifting out of the Affordable Care Act's (ACA) individual and small group markets into AHPs by 2022.

Today, the Trump Administration released its budget for fiscal year 2019 (FY 2019).

Avalere experts provide their insights on what the impact of coverage gap discount changes in budget agreement.

Kenny Kan has joined the Avalere team leading the firm's actuarial analytics. Prior to joining Avalere, Kan served as the Chief Actuary at Humana and CareFirst.

Gillian Wollett, Senior Vice President of Avalere’s FDA & Regulatory Policy team, recently published “A ‘Global Reference’ Comparator for Biosimilar Development” in BioDrugs.

Analysis also finds that 62% of impacted facilities will experience less than a 5% reduction in Medicare Part B revenue due to the drug cuts, but 6% of applicable hospitals will experience cuts greater than 10%.

Brow was most recently regional SVP of The US Oncology Network for McKesson.

Avalere's President and Founder, Dan Mendelson, recently wrote a column about the new strategies that device manufacturers should take in this era of healthcare.

Today, Avalere announced that it has massively expanded its data and analytic capabilities through certification under the Centers for Medicare & Medicaid Services (CMS) Qualified Entity (QE) program.

On Tuesday, June 13, Christie Teigland, PhD, will participate in a panel discussion entitled “Measuring and Reporting Social Risk Factors” as part of a dissemination meeting on the report series “Accounting for Social Risk Factors in Medicare Payment,” sponsored by the National Academies of Medicine.

Tom Kraus, who most recently served as the chief of staff at the FDA, will be joining Avalere as senior vice president.

Sean Creighton has joined the Avalere team as a vice president in the policy practice, and will be responsible for leading advisory services work tied to Medicare Advantage, risk adjustment, and related issues.

Scott Peterson, formerly Chief Information Officer at the Minnesota Department of Human Services, is joining Avalere’s Data Analytics and Development team.

Avalere will empower expanded insight and improvement in outcomes for value-based diabetes medications, using Inovalon’s data resources and advanced value-based care platforms.

Avalere Vice President, Christie Teigland, PhD, was recently appointed to the Pharmacy Quality Alliance’s (PQA) Quality Metrics Expert Panel (QMEP) for a three-year term effective January 1, 2017.

Results from a new Avalere study will be presented Thursday, October 27, at the 30th Annual North American Cystic Fibrosis Conference in Orlando, Florida.

Avalere experts predict that one-third of the country will have no exchange plan competition in 2017, leaving consumers with few options for coverage.

Data show gaps in care integration across provider settings following hospital discharges.

Wendy Everett, ScD, joins Avalere as a senior advisor.

Avalere and Inovalon recently entered into an agreement with Bristol-Meyers Squibb (BMS) to support the manufacturer's innovative initiatives using real-world outcomes data to design and test value-based contracting models. The agreement brings together Avalere's deep expertise on manufacturer and payer contract negotiation and Inovalon's significant data assets to meet the complex challenges around ensuring value and access while addressing growing healthcare costs concerns.

Christie Teigland, PhD, vice president, Advanced Analytics, recently received the Academy of Managed Care Pharmacy’s (AMCP) prestigious Platinum Award for her research entitled “Association of Socioeconomic and Clinical Factors with Rates of High-Risk Medication Use in Medicare Advantage Plans.”

Avalere and Inovalon have entered into a multi-year agreement with Kindred Healthcare, Inc., the nation’s largest provider of post-acute care (PAC) services, to deploy the power of data and analytics to engage payers. The combined solutions will result in a data-driven platform that will support Kindred in improving clinical outcomes and promoting coordinated, efficient care under new value-based payment models.

Fred Bentley, an experienced leader in payment and delivery system reform, has joined Avalere’s Center for Payment & Delivery Innovation. Fred will supplement our existing deep expertise in provider strategy and provide analytic and strategic support on issues related to care delivery.

In 2016, 2 key themes underlie much of the shift in the healthcare landscape: cost and value. Each of these elements is critical as we attempt to reduce costs by improving value across the healthcare system. Caroline Pearson, Senior Vice President, Strategy and Policy, gives a preview of what to expect.

Sheila Fifer, PhD, and Randel Richner, BSN, MPH, have joined Avalere as senior advisors.

We are excited to share with you the next phase in Avalere’s journey.

Avalere won second place in the 2nd Annual LINK Innovation Competition for its Vantage Care Positioning System (CPS).

Avalere senior vice president, Gillian Woollett, has been appointed to the U.S. Pharmacopeial Convention’s Nomenclature and Labeling Expert Committee (NLEC).

The health insurance company Aetna announced Friday it will buy rival Humana for $37 billion. The merger comes as other health insurers consider consolidating to cut costs. Read NPR's interview with our founder, Dan Mendelson.

The healthcare delivery system is one of the most complex businesses in the country.

New research from Avalere finds that despite the innovation of abuse-deterrent properties and labeling for branded opioids, Medicare Part D plan coverage for these products is declining rapidly.

Avalere Health today announced the hiring of Nancy McGee as executive vice president to head its thriving life sciences business unit.

Avalere director, Leigh Ann Bruhn, was recently named to the Academy of Managed Care Pharmacy’s (AMCP) Corporate Member Council.

Avalere director Dr. Lakshman Ramamurthy will be a panelist on the Centers for Medicare and Medicaid Services’ (CMS) Medicare Evidence Development and Coverage Advisory Committee (MEDCAC), which will meet on Tuesday, March 24.

As healthcare leaders and policymakers look to curb spending and improve quality, they should examine models like the Alternative Quality Contract (AQC), according to a new paper by Avalere.

Lisa Latts, MD, and Rick Smith join Avalere's team.

Sheahan will lead Avalere Communications, a rapidly growing group within Avalere Health that brings deep substantive and innovative strategic thinking to healthcare communications.

Avalere-Pope Woodhead collaboration a natural fit to deliver global market services

Avalere Health announced today that Lindy Hinman will be re-joining the company as senior vice president, leading its Health Plans and Managed Care Practice.

New Avalere research for The SCAN Foundation demonstrates the ROI potential of well-targeted care coordination programs supported by robust data.

New team members add depth and experience across multiple health policy issues.

Lakshman Ramamurthy, PhD, director of FDA & Regulatory Policy at Avalere Health, has been appointed by the Centers for Medicare and Medicaid (CMS) to serve as an industry representative to the Medicare Evidence Development & Coverage Advisory Committee (MEDCAC).

This month, Avalere Health proudly joins the Health Data Consortium (HDC), an organization comprising government, private sector, and non-for-profit entities, whose goal is to improve health and healthcare by advancing the availability and innovative use of data.


In this year's Outlook, Avalere experts analyze which key events will impact your industry most, and when to start to prepare.